https://www.law360.com/health/articles/2283/immunomedics-settles-patent-suit-vs-cytogen?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-11T00:23:37Z monthly 0.5 https://www.law360.com/health/articles/2292/e-u-eyes-six-month-marketing-exclusivity-for-pediatric-testing?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-11T17:22:21Z monthly 0.5 https://www.law360.com/health/articles/2280/trial-date-set-in-orasure-patent-suit-vs-schering-plough?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-11T06:44:51Z monthly 0.5 https://www.law360.com/health/articles/2279/court-denies-preliminary-injunction-in-thermage-patent-suit-vs-syneron?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-12T07:21:16Z monthly 0.5 https://www.law360.com/health/articles/2278/court-awards-integra-lifesciences-6-4m-in-patent-suit-vs-merck-kgaa?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-11T19:20:26Z monthly 0.5 https://www.law360.com/health/articles/2282/impax-gets-fda-ok-for-generic-oxycontin-?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-11T05:14:34Z monthly 0.5 https://www.law360.com/health/articles/2273/medtronic-slapped-with-110m-in-damages-in-patent-suit-over-medical-devices?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-11T21:03:14Z monthly 0.5 https://www.law360.com/health/articles/2265/pfizer-appeals-china-s-decision-to-overturn-viagra-patent?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-12T05:37:44Z monthly 0.5 https://www.law360.com/health/articles/2267/india-eyes-system-for-pre-grant-patent-opposition-in-new-patent-regime?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-10T23:14:12Z monthly 0.5 https://www.law360.com/health/articles/2266/judge-postpones-hearing-on-pfizer-bid-to-block-neurontin-generic?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-12T18:39:53Z monthly 0.5 https://www.law360.com/health/articles/2252/judge-adjourns-injunction-hearing-in-neurontin-case?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-12T18:39:52Z monthly 0.5 https://www.law360.com/health/articles/2240/gen-probe-to-pay-22-5m-to-settle-patent-dispute-with-abbott-unit?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-11T20:10:06Z monthly 0.5 https://www.law360.com/health/articles/2237/cooley-hires-biotech-patent-attorneys-for-reston-office?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-12T15:55:10Z monthly 0.5 https://www.law360.com/health/articles/2223/drug-companies-target-india-for-r-d-under-new-patent-regime?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-12T06:11:02Z monthly 0.5 https://www.law360.com/health/articles/2224/novartis-sues-teva-over-anda-for-generic-lotrel?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-10T23:22:30Z monthly 0.5 https://www.law360.com/health/articles/2216/pfizer-lobbies-china-s-ip-office-to-restore-viagra-patent-?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-11T14:55:27Z monthly 0.5 https://www.law360.com/health/articles/2206/judge-overturns-7-1m-jury-verdict-vs-umbilical-cord-blood-banks?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-11T22:17:32Z monthly 0.5 https://www.law360.com/health/articles/2201/astrazeneca-sues-kv-pharma-over-anda-for-toprol-xl-generic?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-12T00:18:20Z monthly 0.5 https://www.law360.com/health/articles/2205/u-s-mulls-reinstating-israel-on-ipr-blacklist?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-12T16:42:45Z monthly 0.5 https://www.law360.com/health/articles/2174/american-medical-systems-to-pay-2-5m-to-settle-patent-dispute-with-mentor?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-12T07:42:20Z monthly 0.5 https://www.law360.com/health/articles/2179/schwarz-to-push-for-damages-in-univasc-patent-suit-vs-teva?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-12T00:20:22Z monthly 0.5 https://www.law360.com/health/articles/2150/alpharma-asks-appeals-court-to-remove-stay-on-neurontin-capsule-launch-?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-12T06:53:42Z monthly 0.5 https://www.law360.com/health/articles/2164/teva-agrees-to-suspend-sales-of-moexipril-pending-patent-suit-outcome?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-12T11:10:54Z monthly 0.5 https://www.law360.com/health/articles/2162/israel-prepares-for-clash-with-u-s-e-u-over-drug-patent-policy?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-11T08:53:30Z monthly 0.5 https://www.law360.com/health/articles/2140/roche-to-pay-chiron-78m-to-settle-patent-dispute?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-10T22:55:04Z monthly 0.5 https://www.law360.com/health/articles/2145/suit-claims-albertson-s-drug-companies-abused-prescription-records?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-11T21:12:01Z monthly 0.5 https://www.law360.com/health/articles/2135/india-stays-exclusive-marketing-rights-for-eli-lilly-s-cialis?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-11T07:04:29Z monthly 0.5 https://www.law360.com/health/articles/2133/israel-mulls-ip-bill-that-would-defy-u-s-european-demands?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-11T14:31:03Z monthly 0.5 https://www.law360.com/health/articles/2134/india-s-generic-industry-sounds-alarm-over-planned-patent-overhaul?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-12T18:46:03Z monthly 0.5 https://www.law360.com/health/articles/2121/applera-sues-thermo-electron-over-mass-spectrometer-patent?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-12T02:36:48Z monthly 0.5 https://www.law360.com/health/articles/2122/novo-nordisk-to-appeal-decision-on-norditropin?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-11T14:33:24Z monthly 0.5 https://www.law360.com/health/articles/2116/novartis-faces-uphill-battle-for-patent-extensions-in-europe?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-11T00:10:44Z monthly 0.5 https://www.law360.com/health/articles/2120/fda-holds-off-on-biogenerics-decision?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-11T03:36:59Z monthly 0.5 https://www.law360.com/health/articles/2109/china-defends-decision-to-revoke-viagra-patent?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-12T16:51:07Z monthly 0.5 https://www.law360.com/health/articles/2111/otsuka-seeks-re-examination-of-abilify-patent-due-to-error-in-original-filing?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-12T06:29:12Z monthly 0.5 https://www.law360.com/health/articles/2099/pfizer-sues-18-online-vendors-of-generic-lipitor?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-11T23:25:14Z monthly 0.5 https://www.law360.com/health/articles/2096/novartis-prevails-in-patent-suit-vs-dr-reddy-s-over-lamisil?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-11T14:09:57Z monthly 0.5 https://www.law360.com/health/articles/2082/impax-loses-bid-for-generic-version-of-rilutek-?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-12T00:16:23Z monthly 0.5 https://www.law360.com/health/articles/2081/federal-circuit-sends-guidant-s-140m-lawsuit-vs-st-jude-back-to-district-court?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-11T09:07:43Z monthly 0.5 https://www.law360.com/health/articles/2073/serono-sues-cell-genesys-over-tkt-gene-activation-patent?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-11T00:10:43Z monthly 0.5 https://www.law360.com/health/articles/2079/mylan-laboratories-to-refile-hatch-waxman-suit-vs-fda?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-11T00:15:10Z monthly 0.5